Jade Biosciences Inc (JBIO) — Smart Money Tracker (13F, Q2 2026)

JBIO ranks #3555 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

JBIO is a top-conviction position for Versant Venture Management, LLC — at 13.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in JBIO belongs to FMR LLC, but the position matters far more to Versant Venture Management, LLC, who has 13.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

JBIO is down 2.1% today, but institutions show net buying of $531.9M this quarter — a divergence between today's price move and the underlying institutional flow.

JBIO reported a net loss of $127.4M in its latest fiscal year.

• Not yet profitable — net loss of $127.4M in the latest fiscal year
• Operating cash flow was negative, using $94.7M in cash
• Current ratio of 21.09x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.05x equity — within a conventional range